a pilot phase ii study of neoadjuvant triplet chemotherapy
phase ib pilot study to evaluate reparixin in combination with
igs/bipm pilot project: gps carrier phase for time/frequency
risk biomarkers by high-dose omega-3 fatty acids: phase ii pilot
risk biomarkers by high-dose omega-3 fatty acids: phase ii pilot